Biotech Investors & VC Firms in United States
1265 firms in this list, with a median first check of $500K. 278 of them lead rounds. Generated from verified public data and updated continuously.
Invus
New YorkPre-Seed–Late Stage
8 people
Virginia Venture Partners
RichmondPre-Seed–Series A$100K
11 people
APERTURE Venture Partners
BostonSeed–Series C$1M – $5M
4 people
Cultivian Sandbox Ventures
ChicagoSeed–Late Stage$5M – $15M
7 people
CU Healthcare Innovation Fund
AuroraSeed–Series A
6 people
Moth Fund
San FranciscoPre-Seed–Seed
3 people
Plains Ventures
Oklahoma CitySeed–Series A$250K – $1M
3 people
PureTech Health
Boston
15 people
Sycamore Ventures
PrincetonGrowth–Late Stage$5M – $20M
14 people
Commodore Capital
New YorkSeries C–Late Stage
16 people
Easton Capital
New YorkSeed–Late Stage$10M – $20M
7 people
Ohio Innovation Fund
DublinSeed–Series A$500K – $4M
4 people
Overwater Ventures Llc
Palo AltoPre-Seed–Series A$400K – $2M
7 people
Partnership Fund for NYC
New York CitySeed–Growth
10 people
Salveo Capital
NorthbrookSeed–Late Stage
10 people
Harbor Light Capital Partners
KeeneSeed–Series A$1M – $5M
8 people
Ev3 Ventures Llc
New YorkPre-Seed–Series A$500K – $3M
2 people
Hemi Ventures, Llc
Palo AltoPre-Seed–Series A$250K – $500K
2 people
Alix Ventures
San FranciscoPre-Seed–Series A$100K – $500K
13 people
iNetworks
PittsburghSeed–Late Stage
11 people
SigmaBleyzer
HoustonGrowth$5.4M – $54M
13 people
Emerald Development Managers
New YorkSeed–Late Stage
9 people
Prolog Ventures
ClaytonSeries A–Late Stage$250K – $1M
6 people
Solasta Ventures
BostonSeed–Series C
6 people
Related lists
Investors & VC Firms in North America (13808)Investors & VC Firms in United States (12951)Investors & VC Firms in Europe (5511)Crypto & Web3 Investors & VC Firms (4813)Investors & VC Firms in Global (4134)SaaS Investors & VC Firms (3860)AI & Machine Learning Investors & VC Firms (3764)Fintech Investors & VC Firms (3709)Investors & VC Firms in Asia-Pacific (3560)Healthtech Investors & VC Firms (3408)
Data sourced from public filings and firms' own websites — see our methodology.



















































































